JSPR · Jasper Therapeutics, Inc.
$0.60
-0.03 (-5.21%)
At close · Jul 29
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$16.80M
Shares
28.00M
Jasper Therapeutics, Inc. Earnings Call Transcripts
Every quarterly earnings call for Jasper Therapeutics, Inc. (JSPR) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY26 · Q1
2026-06-12
Jasper Therapeutics, Inc. Q1 FY2026 Earnings Call
Diluted EPS
$-0.04
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q3
2025-11-10
Jasper Therapeutics, Inc. Q3 FY2025 Earnings Call
Diluted EPS
$-1.13
Audio
Transcript
Slides
8-K10-Q
Showing 1–2 of 2 earnings calls